Mechanism of pancreatic β-cell dusfunction in db/db mice and approach for protection of the cell function
Mechanism of pancreatic β-cell dusfunction in db/db mice and approach for protection of the cell function
批准号:
13671204
负责人:
KAKU Kohei
金额:
$0.45万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Prevention of the pancreatic β- cell dysfunction progressed in diabetes mellitus is important subject in the long- tern management of this disease. Preventive effects of diazoxide and pioglitazone on the pancreatic β- cell damage were evaluated using C57BL/KsJ db + /db mice (db + /db + mice), obese diadetic animal model. Long- term trearment (6- 18 weeks of age in db + /db + mice) with diazoxide (100 mg/kg daily p. o.) or pioglitazone (100 mg/kg daily p. o) induced a significant reduction of the fasting blood glucose level (p< 0.05 vs untreated control, at 18 weeks of age). The % islet area was larger in both diazoxide- and pioglitazone- treated mice than in untreated control db + /db + mice (p< 0.001). The β- cell ratio was also significantly larger in pioglitazone- treated mice than in the control mice (p< 0.01). In short- term experiment (10- 12 weeks of age), plasma levels of glucose, tiglyceride, and free fatty acid were significantly decreased by the treatment with diazoxide or pioglitazone. Plasma adiponectin level was increased significantly in both diazoxide- and pioglitazone- treated mice. This level was further increased by combined treatment with diazoxide and pioglitazone (p< 0.001 vs control). Pioglitazone, but not diazoxide, significantly increased insulin sensitivity (p< 0.01). Triglyceride content in pancreatic islets from the control mice was significantly reduced by the treatment with pioglitazone, but not with diazoxide (p< 0.05). Imparied glucose- stimulated insulin secretion from pancreatic islets in the control mice was restored by the treatment with dizoxide or pioglitazone (p< 0.05). The present results suggest that diazoxide directly reduces the pancreatic β- cell overwork and improves the glucose toxicity in db + /db + mice, resulting in the control of β-cell damage. On the other hand, pioglitazone improves the glucolipotoxicity by increasing insulin sensitivity and reducing fat accumulation in the islets in db + /db + mice
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kawsaki F et al.: "Rescue of beta-cell exhaustion after the development of diabetes mellitus in db/db mice"Diabetologia. 44. 147A (2001)
Kawsaki F 等人:“db/db 小鼠患糖尿病后β细胞衰竭的拯救”Diabetologia。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kawasaki F et al.: "Rescue of beta-ceif exhaustion afterthe developmentof diabetes mellitus in db/db mice"Diabetologia. 44. 147A (2001)
Kawasaki F 等人:“db/db 小鼠糖尿病发生后 β-ceif 衰竭的救援”Diabetologia。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kawasaki F et al.: "Prevention of pancreatic b-cell damage by pharmacological interventions in db/db mice-implications for glucolipotoxicity mechanism"Diabetolgia. 45. 146A (2002)
Kawasaki F 等人:“在 db/db 小鼠中通过药物干预预防胰腺 B 细胞损伤 - 对糖脂毒性机制的影响”糖尿病。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Matsuda M, et al.: "Rescue of pancreatic beta-cell exhaustion by diazoxide after the development of diabetes mellitus in rats with streptozotocin-induced diabetes"Eur. J. Pharmacol.. 453. 141-148 (2002)
Matsuda M 等人:“链脲佐菌素诱导的糖尿病大鼠发生糖尿病后,通过二氮嗪挽救胰腺 β 细胞衰竭”Eur。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
川崎史子他: "薬剤介入によるdb/dbマウス膵b細胞機能保持の機序"糖尿病. 45. 210S (2002)
Fumiko Kawasaki 等人:“通过药物干预保存 db/db 小鼠胰腺 B 细胞功能的机制”糖尿病。 45. 210S (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 16 条
Molecular mechanism of visceral obesity controlled by endothelial cell-related growth factors and the search for a new strategy of adipogenecity control
-
批准号:21591153
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2009
-
负责人:KAKU Kohei
-
依托单位:
Research for molecular mechanism of diabetes development in obese type 2 diabetes model db/db mice
-
批准号:18591008
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.28万
-
财政年份:2006
-
负责人:KAKU Kohei
-
依托单位:
Mechanism of pancreatic β cell dysfunction in obese diabetes model db/db mice
-
批准号:15590962
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2003
-
负责人:KAKU Kohei
-
依托单位:
Analysis of genes involved in the susceptibility to type 2 diabetes
-
批准号:03454517
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.1万
-
财政年份:1991
-
负责人:KAKU Kohei
-
依托单位:
Polymorphisms of Glucose Transporter Genes Associated with Type II Diabetes
-
批准号:01570645
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1989
-
负责人:KAKU Kohei
-
依托单位:
国内基金
海外基金
登录
查看更多内容
有氧运动介导Wnt/β-catenin 信号通路抑制神经炎症改善db/db小鼠认知功能障碍的作用与机制
-
批准号:2025JJ70587
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:吴双双
-
依托单位:
黄精多糖调控 AR 和 STAT-Snail 通路重塑前
列腺上皮细胞表型改善 db/db 小鼠糖尿病性
BPH
-
批准号:TGY24H050012
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:陈璇
-
依托单位:
DB白矮星形成的新通道及其吸积污染的研究
-
批准号:12163005
-
项目类别:地区科学基金项目
-
资助金额:37万元
-
批准年份:2021
-
负责人:朱春花
-
依托单位:
ROS/TRPM2/Calpain介导自噬流受阻在布比卡因加重db/db小鼠神经损伤中的作用机制
-
批准号:81974187
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:刘中杰
-
依托单位:
过氧化还原酶4抑制剂Db2337通过ROS/ERs通路诱导肺癌细胞焦亡的作用和机制研究
-
批准号:81903074
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:汪佳兵
-
依托单位:
0-dB功率回退超高速QAM发射机硅基芯片集成技术研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:孟祥雨
-
依托单位:
运动联合二甲双胍“错峰”干预对db/db小鼠肝脏糖脂代谢的分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2019
-
负责人:
-
依托单位:
基于补气固摄理论探讨芪参益气滴丸对db/db小鼠蛋白尿的治疗作用
-
批准号:81803858
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:周澧
-
依托单位:
MiR-320通过抑制PI3K-AKt-CREB信号通路调控糖尿病db/db小鼠认知功能障碍的研究
-
批准号:2018JJ2347
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2018
-
负责人:凌宏艳
-
依托单位:
微流体芯片应用于Db轻同族元素Nb,Ta的萃取方法研究
-
批准号:11705243
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2017
-
负责人:杨春莉
-
依托单位: